On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Lineage Cell Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Lineage Cell Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Lineage Cell Therapeutics (United States)?

ScholarIQrecord summary

Lineage Cell Therapeutics (United States) is a research organisation in Carlsbad, United States. OpenAlex records 344 works and 34,717 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Lineage Cell Therapeutics (United States) have?

ScholarIQindexed works

Lineage Cell Therapeutics (United States) has 344 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Lineage Cell Therapeutics (United States) have?

ScholarIQcitation count

Lineage Cell Therapeutics (United States) has 34,717 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Lineage Cell Therapeutics (United States)?

ScholarIQresearcher count

Lineage Cell Therapeutics (United States) has 1 researchers in the ScholarIQ index.

What is the average h-index at Lineage Cell Therapeutics (United States)?

ScholarIQavg h-index

Lineage Cell Therapeutics (United States) has an average h-index of 44 in OpenAlex.

What is the ROR of Lineage Cell Therapeutics (United States)?

ScholarIQror

The ROR for Lineage Cell Therapeutics (United States) is on the source record.

What is the OpenAlex record for Lineage Cell Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Lineage Cell Therapeutics (United States) is on the source record.

Who are the most-cited researchers behind Lineage Cell Therapeutics (United States)?

ScholarIQtop researchers by citations
1
Xin Huang · Advanced Breast Cancer Therapies
145 works16,419 citations

What are the most-cited papers on Lineage Cell Therapeutics (United States)?

ScholarIQmost cited works
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan, Herbert H. Loong, Melissa L. Johnson, Justin F. Gainor, Caroline E. McCoach, Oliver Gautschi, Benjamin Besse, Byoung Chul Cho, Nir Peled, Jared Weiss, Yu-Jung Kim, Yuichiro Ohe, Makoto Nishio, Keunchil Park, Jyoti D. Patel, Takashi Seto, Tomohiro Sakamoto, Ezra Y. Rosen, Manisha H. Shah, Fabrice Barlési, Philippe A. Cassier, Lyudmila Bazhenova, Filippo de Braud, Elena Garralda, Vamsidhar Velcheti, Miyako Satouchi, Kadoaki Ohashi, Nathan A. Pennell, Karen L. Reckamp, Grace K. Dy, Jürgen Wolf, Benjamin Solomon, Gerald S. Falchook, Kevin Ebata, Michele Nguyen, Binoj C. Nair, Edward Y. Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S. Michael Rothenberg, Kōichi Goto, Vivek Subbiah
New England Journal of Medicine. 2020842 CitationsOPEN ACCESS
Efficacy of Selpercatinib in <i>RET</i> -Altered Thyroid Cancers
Lori J. Wirth, Eric J. Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen H. Lorch, Francis P. Worden, Marcia S. Brose, Jyoti D. Patel, Sophie Leboulleux, Yann Godbert, Fabrice Barlési, John C. Morris, Taofeek K. Owonikoko, Daniel S.W. Tan, Oliver Gautschi, Jared Weiss, Christelle de la Fouchardière, Mark E. Burkard, Janessa Laskin, Matthew H. Taylor, Matthias Kroiß, Jacques Médioni, Jonathan W. Goldman, Todd M. Bauer, Benjamin Levy, Viola W. Zhu, Nehal J. Lakhani, Víctor Moreno, Kevin Ebata, Michele Nguyen, Dana Heirich, Edward Y. Zhu, Xin Huang, Luxi Yang, Jennifer Kherani, S. Michael Rothenberg, Alexander Drilon, Vivek Subbiah, Manisha H. Shah, Maria E. Cabanillas
New England Journal of Medicine. 2020788 CitationsOPEN ACCESS

How much of the research on Lineage Cell Therapeutics (United States) is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
100%
Closed
0%
470M+ articles · free account